Genzyme Sued by Investors Over Sanofi Buyout Bid

Genzyme Corp., which spurned Sanofi-Aventis SA’s $18.5 billion takeover bid, was sued by investors who contend the biotechnology company is wrongfully depriving shareholders of the chance to profit from the offer.
Bloomberg